CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation

S M Coomes, Y Kannan, V S Pelly, L J Entwistle, R Guidi, J Perez-Lloret, N Nikolov, W Müller, M S Wilson, S M Coomes, Y Kannan, V S Pelly, L J Entwistle, R Guidi, J Perez-Lloret, N Nikolov, W Müller, M S Wilson

Abstract

Interleukin-10 (IL-10) is an important regulatory cytokine required to control allergy and asthma. IL-10-mediated regulation of T cell-mediated responses was previously thought to occur indirectly via antigen-presenting cells. However, IL-10 can act directly on regulatory T cells and T helper type 17 (Th17) cells. In the context of allergy, it is therefore unclear whether IL-10 can directly regulate T helper type 2 (Th2) cells and whether this is an important regulatory axis during allergic responses. We sought to determine whether IL-10 signaling in CD4+ Th2 cells was an important mechanism of immune regulation during airway allergy. We demonstrate that IL-10 directly limits Th2 cell differentiation and survival in vitro and in vivo. Ablation of IL-10 signaling in Th2 cells led to enhanced Th2 cell survival and exacerbated pulmonary inflammation in a murine model of house dust mite allergy. Mechanistically, IL-10R signaling regulated the expression of several genes in Th2 cells, including granzyme B. Indeed, IL-10 increased granzyme B expression in Th2 cells and led to increased Th2 cell death, identifying an IL-10-regulated granzyme B axis in Th2 cells controlling Th2 cell survival. This study provides clear evidence that IL-10 exerts direct effects on Th2 cells, regulating the survival of Th2 cells and severity of Th2-mediated allergic airway inflammation.

References

    1. J Exp Med. 2005 Dec 5;202(11):1459-63
    1. Bioinformatics. 2015 Jan 15;31(2):166-9
    1. Lancet. 1998 Jul 11;352(9122):113
    1. Bioinformatics. 2010 Jan 1;26(1):139-40
    1. J Biomed Biotechnol. 2010;2010:202397
    1. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5126-31
    1. Immunity. 2006 Aug;25(2):237-47
    1. Cancer Cell. 2011 Dec 13;20(6):781-96
    1. Genome Biol. 2013 Apr 25;14(4):R36
    1. J Clin Invest. 1998 Jul 1 ;102(1):98-106
    1. Immunity. 2001 Aug;15(2):303-11
    1. Nat Immunol. 2015 Oct;16(10):1051-9
    1. J Immunol. 1995 Aug 1;155(3):1079-90
    1. J Exp Med. 2002 Mar 4;195(5):603-16
    1. Bioinformatics. 2014 Aug 1;30(15):2114-20
    1. J Exp Med. 1991 Oct 1;174(4):915-24
    1. Science. 2000 Aug 25;289(5483):1352-5
    1. Curr Opin Immunol. 2008 Jun;20(3):339-43
    1. J Allergy Clin Immunol. 2004 Jun;113(6):1109-16
    1. J Immunol. 2015 Feb 1;194(3):887-97
    1. Nat Immunol. 2004 Nov;5(11):1157-65
    1. Eur J Immunol. 2010 Feb;40(2):443-8
    1. J Immunol. 1991 May 15;146(10):3444-51
    1. J Immunol. 2006 Mar 15;176(6):3470-9
    1. Eur J Immunol. 2003 May;33(5):1205-14
    1. Immunity. 2011 Apr 22;34(4):554-65
    1. Immunity. 2011 Apr 22;34(4):566-78
    1. Clin Exp Allergy. 2000 Jun;30(6):775-83
    1. J Allergy Clin Immunol. 2015 Mar;135(3):771-80.e8
    1. Eur J Immunol. 2007 Mar;37(3):807-17
    1. J Immunol. 2012 Jun 1;188(11):5478-88
    1. BMC Immunol. 2014 Feb 25;15:9
    1. Nat Immunol. 2007 Sep;8(9):931-41
    1. J Biol Chem. 1998 Mar 13;273(11):6132-8
    1. J Clin Invest. 2007 Oct;117(10):2941-51
    1. Immunity. 2005 Oct;23(4):419-29
    1. J Exp Med. 2011 May 9;208(5):1027-40
    1. J Immunol. 1994 May 1;152(9):4368-74
    1. Am J Respir Crit Care Med. 1998 Jan;157(1):256-62
    1. Immunity. 2011 Jan 28;34(1):39-49
    1. Annu Rev Immunol. 1993;11:165-90
    1. J Exp Med. 1997 Mar 17;185(6):1089-99
    1. Immunity. 2002 Feb;16(2):311-23
    1. J Allergy Clin Immunol. 1996 Jun;97(6):1288-96

Source: PubMed

3
Subscribe